This is the authors' abstract. We don't add key points for this paper.
Six new 2-morpholinoethyl and 2-diethylaminoethyl substituted N-heterocyclic carbene (NHC) silver complexes (2a-f) were synthesized from the reaction 1-(2-morpholinoethyl)-3-napthalenomethlbenzimidazolium chloride (1a), 1-(2-morpholinoethyl)-3-(2-methylbenzyl)benzimidazolium chloride (1b), 1-(2-morpholinoethyl)-3-(2,3,5,6-tetramethylbenzyl)benzimidazolium chloride (1c), [1-(2-diethylaminoethyl)-3-(3-methylbenzyl)benzimidazolium chloride (1d), [1-(2-diethylaminoethyl)-3-(2,3,5,6-tetramethylbenzyl)benzimidazolium chloride (1e), [1-(N,N-diethylethane)-3-(2,3,4,5,6-pentamethylbenzyl)benzimidazolium chloride (1f) with silver oxide (Ag2O) in dichloromethane at room temperature. These silver complexes were characterized by means of 1H NMR, 13C NMR, FT-IR spectroscopy and elemental analysis techniques. Also, [1-(N,N-diethylethane)-3-(2,3,4,5,6-pentamethylbenzyl)benzimidazol-2-ylidene]chlorosilver(I) complex (2f) was characterized by means of LC-MS and Maldi-MS methods. All silver complexes (2a-f) were screened for their in vitro antimicrobial activities against the following standard strains: Enterococcus faecalis, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and the fungi Candida tropicalis, Candida albicans by using the microdilution broth method. These new compounds showed effective antimicrobial activities against gram-negative bacterial strains, gram-positive bacterial strains, and fungus. Also, ampicillin, ciprofloxacin, and fluconazole as the antibacterial standard drugs were used for comparison with synthesized new unsymmetrically substituted NHC silver complexes (2a-f).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Akkoç et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: